{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:51:32Z","timestamp":1649145092684},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11883-015-0542-5","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T21:13:04Z","timestamp":1443215584000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of Endovascular Closure of the Left Atrial Appendage in Stroke Prevention for Atrial Fibrillation"],"prefix":"10.1007","volume":"17","author":[{"given":"Jawad","family":"Kiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"issue":"2","key":"542_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","volume":"37","author":"SS Chugh","year":"2001","unstructured":"Chugh SS et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37(2):371\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"542_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285(18):2370\u20135.","journal-title":"JAMA"},{"issue":"2","key":"542_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119\u201325.","journal-title":"Circulation"},{"issue":"9","key":"542_CR4","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","volume":"110","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042\u20136.","journal-title":"Circulation"},{"issue":"8","key":"542_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","volume":"27","author":"J Heeringa","year":"2006","unstructured":"Heeringa J et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam Study. Eur Heart J. 2006;27(8):949\u201353.","journal-title":"Eur Heart J"},{"issue":"1","key":"542_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/01.STR.0000106761.94985.8B","volume":"35","author":"C Weimar","year":"2004","unstructured":"Weimar C et al. Age and national institutes of health stroke scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke J Cereb Circ. 2004;35(1):158\u201362.","journal-title":"Stroke J Cereb Circ"},{"issue":"10","key":"542_CR7","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1161\/STROKEAHA.111.619049","volume":"42","author":"KK Andersen","year":"2011","unstructured":"Andersen KK, Andersen ZJ, Olsen TS. Predictors of early and late case-fatality in a nationwide Danish study of 26,818 patients with first-ever ischemic stroke. Stroke J Cereb Circ. 2011;42(10):2806\u201312.","journal-title":"Stroke J Cereb Circ"},{"issue":"4","key":"542_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1212\/WNL.0b013e31824367ab","volume":"78","author":"M Knoflach","year":"2012","unstructured":"Knoflach M et al. Functional recovery after ischemic stroke\u2014a matter of age: data from the Austrian Stroke Unit Registry. Neurology. 2012;78(4):279\u201385.","journal-title":"Neurology"},{"issue":"2","key":"542_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ageing\/afh052","volume":"33","author":"LP Kammersgaard","year":"2004","unstructured":"Kammersgaard LP et al. Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing. 2004;33(2):149\u201354.","journal-title":"Age Ageing"},{"issue":"8","key":"542_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","volume":"31","author":"L Friberg","year":"2010","unstructured":"Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31(8):967\u201375.","journal-title":"Eur Heart J"},{"issue":"10","key":"542_CR11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","volume":"27","author":"HJ Lin","year":"1996","unstructured":"Lin HJ et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke J Cereb Circ. 1996;27(10):1760\u20134.","journal-title":"Stroke J Cereb Circ"},{"issue":"10","key":"542_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1161\/01.STR.27.10.1765","volume":"27","author":"HS Jorgensen","year":"1996","unstructured":"Jorgensen HS et al. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke J Cereb Circ. 1996;27(10):1765\u20139.","journal-title":"Stroke J Cereb Circ"},{"issue":"2","key":"542_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","volume":"32","author":"M Lamassa","year":"2001","unstructured":"Lamassa M et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (the European Community Stroke Project). Stroke J Cereb Circ. 2001;32(2):392\u20138.","journal-title":"Stroke J Cereb Circ"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"R Hart","year":"2007","unstructured":"Hart R, Pearce L, Aguilar M. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"issue":"6","key":"542_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","volume":"127","author":"GY Lip","year":"2014","unstructured":"Lip GY et al. \u2018Real-world\u2019 antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med. 2014;127(6):519\u201329. e1.","journal-title":"Am J Med"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/VHRM.S68117","volume":"10","author":"E Yang","year":"2014","unstructured":"Yang E. A clinician\u2019s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation\u2014full speed ahead or proceed with caution. Vasc Health Risk Manag. 2014;10:507\u201322.","journal-title":"Vasc Health Risk Manag"},{"issue":"9921","key":"542_CR17","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362. This was the main sentinel trial \u2018PROTECT AF\u2019 that first evaluated the efficacy and safety of the WATCHMAN device.","journal-title":"Lancet"},{"key":"542_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","volume":"126","author":"DA Lane","year":"2012","unstructured":"Lane DA, Lip GY. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012;126:860. This paper shows the outcomes of the sentinel trial \u2018PROTECT AF\u2019 with 2.3 year follow-up data.","journal-title":"Circulation"},{"issue":"2","key":"542_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755\u20139. This trial focused more definitively on the safety outcomes and complication rates with the WATCHMAN device. It again highlights the importance of the \u2018operator learning curve\u2019.","journal-title":"Ann Thorac Surg"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/europace\/euu174","volume":"16","author":"B Meier","year":"2014","unstructured":"Meier B, Blaauw Y, Khattab AA. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014;16:1397. This registry highlighted the safety outcomes and complication rates with the WATCHMAN device. It highlights the importance of the \u2018operator learning curve\u2019 and showed that with increased operator experience, safety outcomes improve.","journal-title":"Europace"},{"issue":"11","key":"542_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jacc.2008.03.067","volume":"52","author":"A Kanderian","year":"2008","unstructured":"Kanderian A et al. Success of surgical left atrial appendage closure\u2014assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52(11):924\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"542_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ahj.2004.09.054","volume":"150","author":"J Healey","year":"2005","unstructured":"Healey J et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150(2):288\u201393.","journal-title":"Am Heart J"},{"key":"542_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jtcvs.2011.07.052","volume":"142","author":"G Ailawadi","year":"2011","unstructured":"Ailawadi G et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011;142:1002\u20139. This study was the first to show experience with the LARIAT system. It reported the efficacy and safety of the LARIAT.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jtcvs.2009.06.033","volume":"139","author":"S Salzberg","year":"2010","unstructured":"Salzberg S et al. Left atrial appendage clip occlusion: early clinical results. J Thorac Cardiovasc Surg. 2010;139:1269\u201374. This was a larger multicenter study with a larger cohort of LARIAT patients. It highlighted the safety outcomes more and the need for a randomized controlled trial in the future.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"542_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0735-1097(03)00954-9","volume":"42","author":"MA Garcia-Fernandez","year":"2003","unstructured":"Garcia-Fernandez MA et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003;42(7):1253\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"542_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0735-1097(00)00765-8","volume":"36","author":"ES Katz","year":"2000","unstructured":"Katz ES et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000;36(2):468\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"542_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacc.2013.01.017","volume":"62","author":"T Ohtsuka","year":"2013","unstructured":"Ohtsuka T et al. Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation. J Am Coll Cardiol. 2013;62(2):103\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR28","unstructured":"Available from: \n                      http:\/\/news.bostonscientific.com\/2015-03-13-Boston-Scientific-Receives-FDA-Approval-for-WATCHMAN-Left-Atrial-Appendage-Closure-Device\n                      \n                    ."},{"issue":"16","key":"542_CR29","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/01.CIR.0000015698.54752.6D","volume":"105","author":"H Sievert","year":"2002","unstructured":"Sievert H et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002;105(16):1887\u20139.","journal-title":"Circulation"},{"issue":"1","key":"542_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jacc.2005.03.042","volume":"46","author":"SH Ostermayer","year":"2005","unstructured":"Ostermayer SH et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46(1):9\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","volume":"61","author":"V Reddy","year":"2013","unstructured":"Reddy V et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation. J Am Coll Cardiol. 2013;61:2551\u20136. This is the first study to show experience with the AMPLATZER cardiac plug device.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR32","unstructured":"Tzikas A. Left atrial appendage occlusion for stroke prevention in atrial fibrillation\u2014multicenter experience with the Amplatzer Cardiac Plug. in Accepted for publication in EuroIntervention. 2014."},{"issue":"9689","key":"542_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet"},{"key":"542_CR34","doi-asserted-by":"crossref","unstructured":"Reddy V. et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation\u20142.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation, 2013(127): p. 720\u2013729.","DOI":"10.1161\/CIRCULATIONAHA.112.114389"},{"key":"542_CR35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"V Reddy","year":"2014","unstructured":"Reddy V et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrilation\u2014a randomized clinical trial. JAMA. 2014;312:1988\u201398.","journal-title":"JAMA"},{"key":"542_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","volume":"123","author":"V Reddy","year":"2011","unstructured":"Reddy V et al. Safety of percutaneous left atrial appendage closure results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123:417\u201324.","journal-title":"Circulation"},{"key":"542_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"D Holmes","year":"2014","unstructured":"Holmes D et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR38","doi-asserted-by":"crossref","unstructured":"Bajaj N, et al. Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation\u2014a systematic review and analysis of observational studies. J Am Coll Cardiol Intv, 2014 (7):296\u2013304. This paper highlighted the strengths as well as areas that need to be focused on for the future of LAAO therapy.","DOI":"10.1016\/j.jcin.2013.11.010"},{"key":"542_CR39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ccd.25230","volume":"83","author":"I Cruz-Gonzalez","year":"2014","unstructured":"Cruz-Gonzalez I et al. Significance of the learning curve in left atrial appendage occlusion with two different devices. Catheter Cardiovasc Interv. 2014;83:642\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"542_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jacc.2012.06.046","volume":"62","author":"K Bartus","year":"2013","unstructured":"Bartus K et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62(2):108\u201318.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacc.2014.03.057","volume":"64","author":"M Price","year":"2014","unstructured":"Price M et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol. 2014;64:565\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"542_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.hrthm.2010.10.040","volume":"8","author":"K Bartus","year":"2013","unstructured":"Bartus K et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm. 2013;8(2):188\u201393.","journal-title":"Heart Rhythm"},{"issue":"3","key":"542_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCINTERVENTIONS.109.914978","volume":"3","author":"RJ Lee","year":"2010","unstructured":"Lee RJ, Bartus K, Yakubov SJ. Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model. Circ Cardiovasc Interv. 2010;3(3):224\u20139.","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"542_CR44","first-page":"E289","volume":"24","author":"R Shetty","year":"2012","unstructured":"Shetty R, Leitner JP, Zhang M. Percutaneous catheter-based left atrial appendage ligation and management of periprocedural left atrial appendage perforation with the LARIAT suture delivery system. J Invasive Cardiol. 2012;24(11):E289\u201393.","journal-title":"J Invasive Cardiol"},{"issue":"6","key":"542_CR45","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.amjcard.2012.11.061","volume":"111","author":"A Massumi","year":"2013","unstructured":"Massumi A et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013;111(6):869\u201373.","journal-title":"Am J Cardiol"},{"issue":"11","key":"542_CR46","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.hrthm.2014.07.032","volume":"11","author":"MA Miller","year":"2014","unstructured":"Miller MA et al. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device. Heart Rhythm. 2014;11(11):1853\u20139.","journal-title":"Heart Rhythm"},{"issue":"1","key":"542_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10840-015-9993-4","volume":"43","author":"CR Ellis","year":"2015","unstructured":"Ellis CR, Byrd JM, Scalf SL. Ischemic necrosis of the left atrial appendage at autopsy 4\u00a0weeks following epicardial suture ligation via a sub-xiphoid approach (LARIAT). J Interv Card Electrophysiol: Int J Arrhythmias Pacing. 2015;43(1):99\u2013100.","journal-title":"J Interv Card Electrophysiol: Int J Arrhythmias Pacing"},{"issue":"3","key":"542_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ccd.10660","volume":"60","author":"B Meier","year":"2003","unstructured":"Meier B et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60(3):417\u201322.","journal-title":"Catheter Cardiovasc Interv"},{"key":"542_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jacc.2013.02.089","volume":"62","author":"M Urena","year":"2013","unstructured":"Urena M et al. Percutaneous left atrial appendage closure with the amplatzer cardiac plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy. J Am Coll Cardiol. 2013;62:96\u2013102.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR50","unstructured":"2013.icimeeting.com\/wp-content\/uploads\/\u2026\/1722-Martin-I-mon.pdf\n                      \n                    ."},{"issue":"25","key":"542_CR51","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","volume":"61","author":"VY Reddy","year":"2013","unstructured":"Reddy VY et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013;61(25):2551\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"542_CR52","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.jacc.2013.01.061","volume":"61","author":"O Alli","year":"2013","unstructured":"Alli O et al. Quality of life assessment in the randomized PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2013;61(17):1790\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"542_CR53","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA et al. AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57\u2013185.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu278","author":"S Windecker","year":"2014","unstructured":"Windecker S et al. 2014 ESC\/ECATS guidelines on myocardial revascularization. Eur Heart J. 2014. doi:\n                      10.1093\/eurheartj\/ehu278\n                      \n                    .","journal-title":"Eur Heart J"},{"key":"542_CR55","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/europace\/eut043","volume":"15","author":"T Lewalter","year":"2013","unstructured":"Lewalter T et al. An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. Europace. 2013;15:652\u20136.","journal-title":"Europace"},{"key":"542_CR56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jacc.2013.08.1631","volume":"63","author":"D Holmes","year":"2014","unstructured":"Holmes D et al. Left atrial appendage occlusion: opportunities and challenges. J Am Coll Cardiol. 2014;63:291\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"542_CR57","first-page":"2719","volume":"33","author":"AJ Camm","year":"2010","unstructured":"Camm AJ et al. Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2010;33(21):2719\u201347.","journal-title":"Eur Heart J"},{"key":"542_CR58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/AC.68.6.8000001","volume":"68","author":"J Kefer","year":"2013","unstructured":"Kefer J et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with amplatzer cardiac plug: the Belgian Registry. Acta Cardiol. 2013;68:551\u20138.","journal-title":"Acta Cardiol"},{"key":"542_CR59","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","volume":"59","author":"J Viles-Gonzales","year":"2012","unstructured":"Viles-Gonzales J et al. The clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation. J Am Coll Cardiol. 2012;59:923\u20139.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-015-0542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-015-0542-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-015-0542-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-015-0542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T12:14:31Z","timestamp":1581941671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-015-0542-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s11883-015-0542-5","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,26]]},"assertion":[{"value":"26 September 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"65"}}